4
Changes in Ownership
UroGen Pharma Ltd. Filed Acc 0001209191-19-048672
Chief Medical Officer sold 343 shares at $33.92 ($11,635)
- Chief Medical Officer acquired 1,041 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schoenberg Mark · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-09-04 | Exercise or conversion : show line 1 in the form | +1,041 | 6,350 | D | ||
| 2019-09-04 | Sale : show line 2 in the form | −343 | $33.92 | $11,635 | 6,007 | D |
| Open-market sales · 343 sh · avg $33.92 · $11,635 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2019-09-04 | Exercise or conversion : show line 3 in the form Restricted Stock Units (RSUs) | −1,041 | 1,041 | 5,209 | D |
Loading xslF345X03/doc4.xml…